Skip to main content
Erschienen in: Documenta Ophthalmologica 2/2008

01.03.2008 | Original Research Article

Correlation between retinal morphological and functional findings and clinical severity in Parkinson’s disease

verfasst von: Özgül Altintaş, Pervin Işeri, Berna Özkan, Yusuf Çağlar

Erschienen in: Documenta Ophthalmologica | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

Background To measure the parapapillary retinal nerve fiber layer and macular thickness and macular volume in vivo and to evaluate whether retinal structural changes and visual cortical responses may be related to the clinical severity of the PD. Methods We included 17 patients with Parkinson’s disease and 11 healthy subjects of a similar age. Unified Parkinson’s disease rating scale scores in Parkinson’s disease and control subjects were assessed for clinical evaluation. The retinal nerve fiber layer thickness, macular thickness and volume were measured by commercially available optical coherence tomography Model 3000 unit. Peak latencies of P100 component were measured by pattern visual evoked potential examination. Results The mean retinal nerve fiber layer average thickness was significantly reduced in Parkinson’s disease patients (98.76 ± 10.90 μm) when compared with those of control subjects (114.54 ± 5.72) (P < 0.05). The retinal thickness reduction was statistically significant in superior inner macula; temporal, nasal and inferior quadrants of outer macula (P < 0.05)(Table 2). The mean total macular volume of Parkinson’s disease patients (6.82 ± 0.32 mm3) was significantly reduced when compared with those of control subjects (7.09 ± 0.23 mm3). Highly significant inverse correlation between foveal retinal thickness and total and motor subscores of Unified Parkinson’s disease rating scale was observed in Parkinson’s disease patients, respectively (r = −0.660; P = 0.004), (r = −0.625, P = 0.007). There was a moderate nearly significant inverse correlation between total macular volume and P100 latency in PD (r = −0.328; P = 0.058). Conclusions In Parkinson’s disease patients there is a reduction of retinal nerve fiber layer thickness, macular thickness and volume evaluated in vivo by optical coherence tomography. Reduced foveal thickness which is not found to be statistically different from normal is correlated to the severity of disease.
Literatur
1.
Zurück zum Zitat Djamgoz MB, Hankins MW, Hirano J, Archer SN (1997) Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res 37(24):3509–3529PubMedCrossRef Djamgoz MB, Hankins MW, Hirano J, Archer SN (1997) Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res 37(24):3509–3529PubMedCrossRef
2.
Zurück zum Zitat Bodis-Wollner I (1990) Visual deficits related to dopamine deficiency in experimental animals and Parkinson’s disease patients. Trends Neurosci 13(7):296–302PubMedCrossRef Bodis-Wollner I (1990) Visual deficits related to dopamine deficiency in experimental animals and Parkinson’s disease patients. Trends Neurosci 13(7):296–302PubMedCrossRef
3.
Zurück zum Zitat Jackson GR, Owsley C (2003) Visual dysfunction, neurodegenerative diseases and aging. Neurol Clin North Am 21:709–728 Jackson GR, Owsley C (2003) Visual dysfunction, neurodegenerative diseases and aging. Neurol Clin North Am 21:709–728
4.
Zurück zum Zitat Price MJ, Feldman RG, Kayne H (1992) Abnormalities in color vision and contrast sensitivity in Parkinson’s disease. Neurology 42:887–890PubMed Price MJ, Feldman RG, Kayne H (1992) Abnormalities in color vision and contrast sensitivity in Parkinson’s disease. Neurology 42:887–890PubMed
5.
Zurück zum Zitat Bodis-Wollner I, Yahr M (1978) Measurement of visual evoked potentials in Parkinson’s disease. Brain 101:661–671PubMedCrossRef Bodis-Wollner I, Yahr M (1978) Measurement of visual evoked potentials in Parkinson’s disease. Brain 101:661–671PubMedCrossRef
6.
Zurück zum Zitat Harnois C, Di Paolo T (1990) Decreased dopamine in the retinas of patients with Parkinson’s disease. Invest Ophthalmol Vis Sci 31:2473–2475PubMed Harnois C, Di Paolo T (1990) Decreased dopamine in the retinas of patients with Parkinson’s disease. Invest Ophthalmol Vis Sci 31:2473–2475PubMed
7.
Zurück zum Zitat Bodis-Wollner I, Marx MS, Mitra S, Bobak P, Mylin L, Yahr M (1987) Visual dysfunction in Parkinson’s disease loos in spatiotemporal contrast sensitivity. Brain 110:1675–1698PubMedCrossRef Bodis-Wollner I, Marx MS, Mitra S, Bobak P, Mylin L, Yahr M (1987) Visual dysfunction in Parkinson’s disease loos in spatiotemporal contrast sensitivity. Brain 110:1675–1698PubMedCrossRef
8.
Zurück zum Zitat Dinner DS, Lüders H, Hanson M, Lesser RP, Klem G (1985) Pattern evoked potentials (PEPS) in Parkinson’s disease. Neurology 35:610–613PubMed Dinner DS, Lüders H, Hanson M, Lesser RP, Klem G (1985) Pattern evoked potentials (PEPS) in Parkinson’s disease. Neurology 35:610–613PubMed
9.
Zurück zum Zitat Nightingale S, Mitchell KW, Howe JW (1986) Visual evoked cortical potentials and pattern electroretinograms in Parkinson’s disease and control subjects. J Neurol Neurosurg Psychiatry 49:1280–1287PubMedCrossRef Nightingale S, Mitchell KW, Howe JW (1986) Visual evoked cortical potentials and pattern electroretinograms in Parkinson’s disease and control subjects. J Neurol Neurosurg Psychiatry 49:1280–1287PubMedCrossRef
10.
Zurück zum Zitat Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A (2004) Retinal nerve fiber thinning in Parkinson disease. Vision Res 44:2793–2797PubMedCrossRef Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A (2004) Retinal nerve fiber thinning in Parkinson disease. Vision Res 44:2793–2797PubMedCrossRef
11.
Zurück zum Zitat Krivoy D, Gentile R, Liebmann JM, Stegman Z, Rosen R, Walsh JB, Ritch R (1996) Imaging congenital optic disc pit using optical coherence tomography. Arch Ophthalmol 114:165–170PubMed Krivoy D, Gentile R, Liebmann JM, Stegman Z, Rosen R, Walsh JB, Ritch R (1996) Imaging congenital optic disc pit using optical coherence tomography. Arch Ophthalmol 114:165–170PubMed
12.
Zurück zum Zitat Hee MR, Puliafito CA, Wong C, Duker JS et al (1995) Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol 113:1019–1029PubMed Hee MR, Puliafito CA, Wong C, Duker JS et al (1995) Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol 113:1019–1029PubMed
13.
Zurück zum Zitat Hee MR, Puliafito CA, Wong C, Duker JS et al (1995) Optical coherence tomography of macular holes. Ophthalmology 102:748–756PubMed Hee MR, Puliafito CA, Wong C, Duker JS et al (1995) Optical coherence tomography of macular holes. Ophthalmology 102:748–756PubMed
14.
Zurück zum Zitat Guedes V, Schuman JS, Hertzmark E et al (2003) Optical coherence tomography measurement of macular and nerve fiber layer thickness in normal and glaucomatous human eyes. Ophthalmology 110:177–189PubMedCrossRef Guedes V, Schuman JS, Hertzmark E et al (2003) Optical coherence tomography measurement of macular and nerve fiber layer thickness in normal and glaucomatous human eyes. Ophthalmology 110:177–189PubMedCrossRef
15.
Zurück zum Zitat Fahn S (1987) Unified Parkinson’s disease rating scale development comitte and Elton RL, 1987. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Caine D (Eds) Recent developments in Parkinson’s disease. Raven, New York, pp 153–163 Fahn S (1987) Unified Parkinson’s disease rating scale development comitte and Elton RL, 1987. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Caine D (Eds) Recent developments in Parkinson’s disease. Raven, New York, pp 153–163
16.
Zurück zum Zitat Celesia GG, Kauffman D, Cone SB (1986) Simultaneous recording of pattern electroretinography and visual evoked potentials in multiple sclerosis. A method to separate a demyelination from axonal damage to the optic nerve. Arch Neurol 43:1247–1252PubMed Celesia GG, Kauffman D, Cone SB (1986) Simultaneous recording of pattern electroretinography and visual evoked potentials in multiple sclerosis. A method to separate a demyelination from axonal damage to the optic nerve. Arch Neurol 43:1247–1252PubMed
17.
Zurück zum Zitat Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA (1991) Optical coherence tomography. Science 254:1178–1181PubMedCrossRef Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA (1991) Optical coherence tomography. Science 254:1178–1181PubMedCrossRef
18.
Zurück zum Zitat Hee MR, Izatt JA, Swanson EA, Huang D, Schuman JS, Lin CP, Puliafito CA, Fujimoto JG (1995) Optical coherence tomography of the human retina. Arch Ophthalmol 113:325–332PubMed Hee MR, Izatt JA, Swanson EA, Huang D, Schuman JS, Lin CP, Puliafito CA, Fujimoto JG (1995) Optical coherence tomography of the human retina. Arch Ophthalmol 113:325–332PubMed
19.
Zurück zum Zitat Schuman JS (1997) Optical coherence tomography for imaging and quantification of nerve fiber layer thickness. In: Schuman JS (ed) Imaging in glaucoma, Slack Inc., Thorofare, pp 95–130 Schuman JS (1997) Optical coherence tomography for imaging and quantification of nerve fiber layer thickness. In: Schuman JS (ed) Imaging in glaucoma, Slack Inc., Thorofare, pp 95–130
20.
Zurück zum Zitat Jankovic J, Marsden CD (1988) Therapeutic strategies in Parkinson’s disease. In: Jankovic J, Tolosa E (eds) Parkinson’s disease and movefsment disorders. Urban & Schwarzenberg, Baltimore, pp 95–119 Jankovic J, Marsden CD (1988) Therapeutic strategies in Parkinson’s disease. In: Jankovic J, Tolosa E (eds) Parkinson’s disease and movefsment disorders. Urban & Schwarzenberg, Baltimore, pp 95–119
21.
Zurück zum Zitat Lang AE, Lozano AM (1998) Parkinson’s disease—first of two parts. New Engl J Med 339(15):1044–1053PubMedCrossRef Lang AE, Lozano AM (1998) Parkinson’s disease—first of two parts. New Engl J Med 339(15):1044–1053PubMedCrossRef
22.
Zurück zum Zitat Tatton WG, Kwan MM, Verrier MC, Seniuk NA, Theriault E (1990) MPTP produces reversible disappereance of thyrosine hydroxylase containing retinal amacrine cells. Brain Res 527:21–31PubMedCrossRef Tatton WG, Kwan MM, Verrier MC, Seniuk NA, Theriault E (1990) MPTP produces reversible disappereance of thyrosine hydroxylase containing retinal amacrine cells. Brain Res 527:21–31PubMedCrossRef
23.
Zurück zum Zitat Reader TA, Quesney LF (1986) Dopamine in the visual cortex of the cat. Experimentia 42:1242–1244CrossRef Reader TA, Quesney LF (1986) Dopamine in the visual cortex of the cat. Experimentia 42:1242–1244CrossRef
24.
Zurück zum Zitat Parkinson D (1989) Evidence for a dopaminergic innervation of cat primary cortex. Neuroscience 30:171–179PubMedCrossRef Parkinson D (1989) Evidence for a dopaminergic innervation of cat primary cortex. Neuroscience 30:171–179PubMedCrossRef
25.
Zurück zum Zitat Bodis-Wollner I (2003) Neuropsychological and perceptual defects in Parkinson’s disease. Parkinson’s Dis Relat Disord 9(suppl 2):83–89CrossRef Bodis-Wollner I (2003) Neuropsychological and perceptual defects in Parkinson’s disease. Parkinson’s Dis Relat Disord 9(suppl 2):83–89CrossRef
26.
Zurück zum Zitat Iseri PK, Altintas O, Tokay T, Yuksel N (2006) Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 26(1):18–24PubMed Iseri PK, Altintas O, Tokay T, Yuksel N (2006) Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 26(1):18–24PubMed
27.
Zurück zum Zitat Parisi V, Manni G, Spadaro M, Colacino G, Restuccia R, Marchi S, Bucci MG, Pierelli F (1999) Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 40(11):2520–2527PubMed Parisi V, Manni G, Spadaro M, Colacino G, Restuccia R, Marchi S, Bucci MG, Pierelli F (1999) Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 40(11):2520–2527PubMed
28.
Zurück zum Zitat Parisi V, Pierelli F, Coppola G, Restuccia R, Ferrazzoli D, Scassa C, Bianco F, Parisi L, Fattapposta F (2007) Reduction of optic nerve fiber layer thickness in CADASIL. Eur J Neurol 14(6):627–631PubMedCrossRef Parisi V, Pierelli F, Coppola G, Restuccia R, Ferrazzoli D, Scassa C, Bianco F, Parisi L, Fattapposta F (2007) Reduction of optic nerve fiber layer thickness in CADASIL. Eur J Neurol 14(6):627–631PubMedCrossRef
29.
Zurück zum Zitat Tagliati M, Bodis-Wollner I, Yahr MD (1996) The pattern electroretinogram in Parkinson’s disease reveals lack of retinal spatial tuning. Electroencephalogr Clin Neurophysiol 100(1):1–11PubMedCrossRef Tagliati M, Bodis-Wollner I, Yahr MD (1996) The pattern electroretinogram in Parkinson’s disease reveals lack of retinal spatial tuning. Electroencephalogr Clin Neurophysiol 100(1):1–11PubMedCrossRef
30.
Zurück zum Zitat Peppe A, Stanzione P, Pierantozzi M, Semprini R, Bassi A, Santilli AM, Formisano R, Piccolino M, Bernardi G (1998) Does pattern electroretinogram spatial tuning alteration in Parkinson’s disease depend on motor disturbances or retinal dopaminergic loss? Electroencephalogr Clin Neurophysiol 106(4):374–382PubMedCrossRef Peppe A, Stanzione P, Pierantozzi M, Semprini R, Bassi A, Santilli AM, Formisano R, Piccolino M, Bernardi G (1998) Does pattern electroretinogram spatial tuning alteration in Parkinson’s disease depend on motor disturbances or retinal dopaminergic loss? Electroencephalogr Clin Neurophysiol 106(4):374–382PubMedCrossRef
31.
Zurück zum Zitat Ghilardi MF, Bodis-Wollner I, Onofrj MC, Marx MS, Glover AA (1988) Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model. Brain 111(Pt 1):131–149PubMedCrossRef Ghilardi MF, Bodis-Wollner I, Onofrj MC, Marx MS, Glover AA (1988) Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model. Brain 111(Pt 1):131–149PubMedCrossRef
32.
Zurück zum Zitat Seibyl JP, Marek KL, Quinlan D, Sheff K, Zoghbi S, Zea-Ponce Y, Baldwin RM, Fussell B, Smith EO, Charney DS et al (1995) Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson’s disease. Ann Neurol 38(4):589–598PubMedCrossRef Seibyl JP, Marek KL, Quinlan D, Sheff K, Zoghbi S, Zea-Ponce Y, Baldwin RM, Fussell B, Smith EO, Charney DS et al (1995) Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson’s disease. Ann Neurol 38(4):589–598PubMedCrossRef
33.
Zurück zum Zitat Brücke T, Asenbaum S, Pirker W, Djamshidian S, Wenger S, Wöber C, Müller C, Podreka I (1997) Measurement of the dopaminergic degeneration in Parkinson’s disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. J Neural Transm Suppl 50:9–24PubMed Brücke T, Asenbaum S, Pirker W, Djamshidian S, Wenger S, Wöber C, Müller C, Podreka I (1997) Measurement of the dopaminergic degeneration in Parkinson’s disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. J Neural Transm Suppl 50:9–24PubMed
34.
Zurück zum Zitat Varma R, Skaf M, Barron E (1996) Retinal nerve fiber layer thickness in normal human eyes. Ophthalmology 103(12):2114–2119. Erratum in: Ophthalmology 1997 104(2):174PubMed Varma R, Skaf M, Barron E (1996) Retinal nerve fiber layer thickness in normal human eyes. Ophthalmology 103(12):2114–2119. Erratum in: Ophthalmology 1997 104(2):174PubMed
35.
Zurück zum Zitat Sihota R, Sony P, Gupta V, Dada T, Singh R (2006) Diagnostic capability of optical coherence tomography in evaluating the degree of glaucomatous retinal nerve fiber damage. Invest Ophthalmol Vis Sci 47(5):2006–2010PubMedCrossRef Sihota R, Sony P, Gupta V, Dada T, Singh R (2006) Diagnostic capability of optical coherence tomography in evaluating the degree of glaucomatous retinal nerve fiber damage. Invest Ophthalmol Vis Sci 47(5):2006–2010PubMedCrossRef
36.
Zurück zum Zitat Manassakorn A, Nouri-Mahdavi K, Caprioli J (2006) Comparison of retinal nerve fiber layer thickness and optic disk algorithms with optical coherence tomography to detect glaucoma. Am J Ophthalmol 141(1):105–115PubMedCrossRef Manassakorn A, Nouri-Mahdavi K, Caprioli J (2006) Comparison of retinal nerve fiber layer thickness and optic disk algorithms with optical coherence tomography to detect glaucoma. Am J Ophthalmol 141(1):105–115PubMedCrossRef
37.
Zurück zum Zitat Kanamori A, Nakamura M, Escano MF, Seya R, Maeda H, Negi A (2003) Evaluation of the glaucomatous damage on retinal nerve fiber layer thickness measured by optical coherence tomography. Am J Ophthalmol. 135(4):513–520PubMedCrossRef Kanamori A, Nakamura M, Escano MF, Seya R, Maeda H, Negi A (2003) Evaluation of the glaucomatous damage on retinal nerve fiber layer thickness measured by optical coherence tomography. Am J Ophthalmol. 135(4):513–520PubMedCrossRef
38.
Zurück zum Zitat Zeimer R (1998) Application of the retinal thickness analyzer to the diagnosis and management of ocular diseases. Ophthalmol Clin North Am 11:359–379CrossRef Zeimer R (1998) Application of the retinal thickness analyzer to the diagnosis and management of ocular diseases. Ophthalmol Clin North Am 11:359–379CrossRef
Metadaten
Titel
Correlation between retinal morphological and functional findings and clinical severity in Parkinson’s disease
verfasst von
Özgül Altintaş
Pervin Işeri
Berna Özkan
Yusuf Çağlar
Publikationsdatum
01.03.2008
Verlag
Springer-Verlag
Erschienen in
Documenta Ophthalmologica / Ausgabe 2/2008
Print ISSN: 0012-4486
Elektronische ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-007-9091-8

Weitere Artikel der Ausgabe 2/2008

Documenta Ophthalmologica 2/2008 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.